Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study

被引：0

作者：

Rossari, F. ^{[1
]}

Tada, T. ^{[2
]}

Shimose, S. ^{[3
]}

Kudo, M. ^{[4
]}

Yoo, C. ^{[5
]}

Cheon, J. ^{[6
]}

Finkelmeier, F. ^{[7
]}

Lim, H. Y. ^{[8
]}

Presa, J. ^{[9
]}

Masi, G. ^{[10
]}

Bergamo, F. ^{[11
]}

Amadeo, E. ^{[12
]}

Vitiello, F. ^{[13
]}

Foti, S. ^{[13
]}

Persano, M. ^{[14
]}

Piscaglia, F. ^{[15
]}

Scartozzi, M. ^{[16
]}

Cascinu, S. ^{[12
]}

Rimini, M. ^{[12
]}

Gardini, A. Casadei ^{[17
]}

机构：

[1] Univ Vita & Salute San Raffaele Milano, Dept Med Oncol SR Tiget, UniSR, Milan, Italy

[2] Japanese Red Cross Soc Himeji Hosp, Internal Med, Himeji, Hyogo, Japan

[3] Kurume Univ Hosp, Dept Gastroenterol, Kurume, Fukuoka, Japan

[4] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Japan

[5] Univ Ulsan, Oncol Dept, Asan Med Ctr, Coll Med, Seoul, South Korea

[6] Ulsan Univ Hosp, Div Hematol & Oncol, Ulsan, South Korea

[7] Johannes Wolfgang Goethe Univ, Internal Med, Univ Klinikum Frankfurt, Frankfurt, Germany

[8] Sungkyunkwan Univ, Samsung Med Ctr SMC, Dept Med, Sch Med, Seoul, South Korea

[9] Ras os Montes & Alto Douro Hosp Ctr, Liver Unit, Vila Real, Portugal

[10] Univ Hosp Pisa, Unit Med Oncol 2, Pisa, Italy

[11] IRCCS, Oncol 1, Veneto Inst Oncol IOV, Padua, Italy

[12] IRCCS Osped San Raffaele, Med Oncol, Milan, Italy

[13] IRCCS Osped San Raffaele, Oncol, Milan, Italy

[14] AOU Cagliari Osped Civile, Dept Med Oncol, Cagliari, Italy

[15] AOU Policlin S Orsola Malpighi, Div Internal Med, Bologna, Italy

[16] Univ Cagliari, Dept Med Oncol, Cagliari, Italy

[17] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.764

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

185P

引用

页码：S1547 / S1547

页数：1

共 50 条

[1] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
Rossari, Federico
Tada, Toshifumi
Suda, Goki
Shimose, Shigeo
Kudo, Masatoshi
Yoo, Changhoon
Cheon, Jaekyung
Finkelmeier, Fabian
Lim, Ho Yeong
Presa, Jose
Masi, Gianluca
Bergamo, Francesca
Amadeo, Elisabeth
Vitiello, Francesco
Kumada, Takashi
Sakamoto, Naoya
Iwamoto, Hideki
Aoki, Tomoko
Chon, Hong Jae
Himmelsbach, Vera
Iavarone, Massimo
Cabibbo, Giuseppe
Montes, Margarida
Foschi, Francesco Giuseppe
Vivaldi, Caterina
Solda, Caterina
Sho, Takuya
Niizeki, Takashi
Nishida, Naoshi
Steup, Christoph
Hirooka, Masashi
Kariyama, Kazuya
Tani, Joji
Atsukawa, Masanori
Takaguchi, Koichi
Itobayashi, Ei
Fukunishi, Shinya
Tsuji, Kunihiko
Ishikawa, Toru
Tajiri, Kazuto
Ochi, Hironori
Yasuda, Satoshi
Toyoda, Hidenori
Ogawa, Chikara
Nishimura, Takashi
Hatanaka, Takeshi
Kakizaki, Satoru
Shimada, Noritomo
Kawata, Kazuhito
Hiraoka, Atsushi
[J]. LIVER CANCER, 2024,
[2] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
Mara Persano
Margherita Rimini
Toshifumi Tada
Goki Suda
Shigeo Shimose
Masatoshi Kudo
Jaekyung Cheon
Fabian Finkelmeier
Ho Yeong Lim
Lorenza Rimassa
José Presa
Gianluca Masi
Changhoon Yoo
Sara Lonardi
Francesco Tovoli
Takashi Kumada
Naoya Sakamoto
Hideki Iwamoto
Tomoko Aoki
Hong Jae Chon
Vera Himmelsbach
Tiziana Pressiani
Takumi Kawaguchi
Margarida Montes
Caterina Vivaldi
Caterina Soldà
Fabio Piscaglia
Atsushi Hiraoka
Takuya Sho
Takashi Niizeki
Naoshi Nishida
Christoph Steup
Massimo Iavarone
Giovanni Di Costanzo
Fabio Marra
Mario Scartozzi
Emiliano Tamburini
Giuseppe Cabibbo
Francesco Giuseppe Foschi
Marianna Silletta
Masashi Hirooka
Kazuya Kariyama
Joji Tani
Masanori Atsukawa
Koichi Takaguchi
Ei Itobayashi
Shinya Fukunishi
Kunihiko Tsuji
Toru Ishikawa
Kazuto Tajiri
[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
[3] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
Persano, Mara
Rimini, Margherita
Tada, Toshifumi
Suda, Goki
Shimose, Shigeo
Kudo, Masatoshi
Cheon, Jaekyung
Finkelmeier, Fabian
Lim, Ho Yeong
Rimassa, Lorenza
Presa, Jose
Masi, Gianluca
Yoo, Changhoon
Lonardi, Sara
Tovoli, Francesco
Kumada, Takashi
Sakamoto, Naoya
Iwamoto, Hideki
Aoki, Tomoko
Chon, Hong Jae
Himmelsbach, Vera
Pressiani, Tiziana
Kawaguchi, Takumi
Montes, Margarida
Vivaldi, Caterina
Solda, Caterina
Piscaglia, Fabio
Hiraoka, Atsushi
Sho, Takuya
Niizeki, Takashi
Nishida, Naoshi
Steup, Christoph
Iavarone, Massimo
Di Costanzo, Giovanni
Marra, Fabio
Scartozzi, Mario
Tamburini, Emiliano
Cabibbo, Giuseppe
Foschi, Francesco Giuseppe
Silletta, Marianna
Hirooka, Masashi
Kariyama, Kazuya
Tani, Joji
Atsukawa, Masanori
Takaguchi, Koichi
Itobayashi, Ei
Fukunishi, Shinya
Tsuji, Kunihiko
Ishikawa, Toru
Tajiri, Kazuto
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602
[4] Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
Brown, Timothy J.
Mamtani, Ronac
Gimotty, Phyllis A.
Karasic, Thomas B.
Yang, Yu-Xiao
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2345 - 2354
[5] Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
Timothy J. Brown
Ronac Mamtani
Phyllis A. Gimotty
Thomas B. Karasic
Yu-Xiao Yang
[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2345 - 2354
[6] Effectiveness and safety of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: A multicenter, retrospective real-world study in China
Zhang, Hui
Shao, Minghua
Tan, Binbin
Fu, Yin
Yuan
Chen, Hailei
[J]. CANCER RESEARCH, 2024, 84 (06)
[7] Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration
Alkadimi, Munaf
Lucero, Kana
Boyle, Lauren Diaz
Fierro, Maria Elena
Franklin, Kathleen
Nooruddin, Zohra
Mader, Michael
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
Ha, Yeonjung
Cheon, Jaekyung
Hwang, Seong Gyu
Chon, Hong Jae
[J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
[9] Real-world systemic treatment patterns of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC)
Singal, A. G.
Ozgurdal, K.
Fan, X.
Vassilev, Z.
Chen, C-C.
Multani, J. K.
Zhou, Z.
He, J.
Pisa, F.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S867 - S867
[10] REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN THE PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTIINSTITUTIONAL COHORT IN TAIWAN
Kuo, Y. C.
Chang, K. C.
Chen, H. Y.
[J]. VALUE IN HEALTH, 2022, 25 (12) : S475 - S475

← 1 2 3 4 5 →